DGX logo

DGX Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$549.00 M
-$137.00 M-19.97%

December 31, 2024


Summary


Performance

DGX Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDGXbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$549.00 M
-$215.00 M-28.14%

December 31, 2024


Summary


Performance

DGX Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDGXbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

DGX Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-20.0%0.0%
3 y3 years-37.0%0.0%
5 y5 years-53.9%0.0%

DGX Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-37.0%+74.3%-37.0%+335.7%
5 y5-year-53.9%+74.3%-65.8%+335.7%
alltimeall time-53.9%+1912.2%-65.8%+1912.2%

Quest Diagnostics Incorporated Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$549.00 M(-20.0%)
$549.00 M(-28.1%)
Sep 2024
-
$764.00 M(+181.9%)
Jun 2024
-
$271.00 M(-42.8%)
Mar 2024
-
$474.00 M(-30.9%)
Dec 2023
$686.00 M(+117.8%)
$686.00 M(+379.7%)
Sep 2023
-
$143.00 M(+13.5%)
Jun 2023
-
$126.00 M(-28.0%)
Mar 2023
-
$175.00 M(-44.4%)
Dec 2022
$315.00 M(-63.9%)
$315.00 M(-55.0%)
Sep 2022
-
$700.00 M(-11.4%)
Jun 2022
-
$790.00 M(+11.0%)
Mar 2022
-
$712.00 M(-18.3%)
Dec 2021
$872.00 M(-24.7%)
$872.00 M(-11.7%)
Sep 2021
-
$987.00 M(+76.3%)
Jun 2021
-
$560.00 M(-54.5%)
Mar 2021
-
$1.23 B(+6.2%)
Dec 2020
$1.16 B(-2.9%)
$1.16 B(-27.9%)
Sep 2020
-
$1.60 B(+62.4%)
Jun 2020
-
$988.00 M(+188.9%)
Mar 2020
-
$342.00 M(-71.3%)
Dec 2019
$1.19 B(+783.0%)
$1.19 B(+174.7%)
Sep 2019
-
$434.00 M(+59.0%)
Jun 2019
-
$273.00 M(-41.2%)
Mar 2019
-
$464.00 M(+243.7%)
Dec 2018
$135.00 M(-1.5%)
$135.00 M(-48.7%)
Sep 2018
-
$263.00 M(+99.2%)
Jun 2018
-
$132.00 M(+6.5%)
Mar 2018
-
$124.00 M(-9.5%)
Dec 2017
$137.00 M(-61.8%)
$137.00 M(-60.9%)
Sep 2017
-
$350.00 M(+11.5%)
Jun 2017
-
$314.00 M(-14.4%)
Mar 2017
-
$367.00 M(+2.2%)
Dec 2016
$359.00 M(+169.9%)
$359.00 M(-11.6%)
Sep 2016
-
$406.00 M(+43.5%)
Jun 2016
-
$283.00 M(+121.1%)
Mar 2016
-
$128.00 M(-3.8%)
Dec 2015
$133.00 M(-30.7%)
$133.00 M(+8.1%)
Sep 2015
-
$123.00 M(-18.0%)
Jun 2015
-
$150.00 M(-84.6%)
Mar 2015
-
$974.00 M(+407.3%)
Dec 2014
$192.00 M(+2.7%)
$192.00 M(+12.9%)
Sep 2014
-
$170.00 M(+18.1%)
Jun 2014
-
$144.00 M(0.0%)
Mar 2014
-
$144.00 M(-23.0%)
Dec 2013
$187.00 M(-36.8%)
$187.00 M(+18.1%)
Sep 2013
-
$158.28 M(+6.7%)
Jun 2013
-
$148.34 M(+11.0%)
Mar 2013
-
$133.60 M(-54.9%)
Dec 2012
$296.00 M(+79.5%)
$296.00 M(+54.4%)
Sep 2012
-
$191.77 M(+10.4%)
Jun 2012
-
$173.74 M(+19.5%)
Mar 2012
-
$145.44 M(-11.8%)
Dec 2011
$164.89 M(-63.3%)
$164.89 M(+48.8%)
Sep 2011
-
$110.83 M(-39.8%)
Jun 2011
-
$184.22 M(-81.5%)
Mar 2011
-
$994.24 M(+121.3%)
DateAnnualQuarterly
Dec 2010
$449.30 M(-15.9%)
$449.30 M(+0.3%)
Jun 2010
-
$447.89 M(-3.3%)
Mar 2010
-
$463.24 M(-13.3%)
Dec 2009
$534.26 M(+110.4%)
$534.26 M(+116.3%)
Sep 2009
-
$247.03 M(+107.1%)
Jun 2009
-
$119.29 M(-41.6%)
Mar 2009
-
$204.22 M(-19.6%)
Dec 2008
$253.95 M(+51.5%)
$253.95 M(-11.4%)
Sep 2008
-
$286.68 M(+99.9%)
Jun 2008
-
$143.40 M(-15.7%)
Mar 2008
-
$170.02 M(+1.4%)
Dec 2007
$167.59 M(+12.0%)
$167.59 M(+1.8%)
Sep 2007
-
$164.62 M(+34.6%)
Jun 2007
-
$122.30 M(-22.8%)
Mar 2007
-
$158.40 M(+5.9%)
Dec 2006
$149.64 M(+62.4%)
$149.64 M(+42.4%)
Sep 2006
-
$105.11 M(-30.2%)
Jun 2006
-
$150.68 M(-3.7%)
Mar 2006
-
$156.46 M(+69.8%)
Dec 2005
$92.13 M(+25.7%)
$92.13 M(-56.1%)
Sep 2005
-
$210.09 M(+2.9%)
Jun 2005
-
$204.11 M(+136.9%)
Mar 2005
-
$86.16 M(+17.5%)
Dec 2004
$73.30 M(-52.7%)
$73.30 M(-63.5%)
Sep 2004
-
$201.04 M(+45.9%)
Jun 2004
-
$137.80 M(-27.5%)
Mar 2004
-
$190.07 M(+22.7%)
Dec 2003
$154.96 M(+60.1%)
$154.96 M(+70.2%)
Sep 2003
-
$91.07 M(+3.4%)
Jun 2003
-
$88.07 M(+58.4%)
Mar 2003
-
$55.60 M(-42.6%)
Dec 2002
$96.78 M(-20.9%)
$96.78 M(-15.0%)
Sep 2002
-
$113.85 M(+26.7%)
Jun 2002
-
$89.84 M(-39.9%)
Mar 2002
-
$149.43 M(+22.1%)
Dec 2001
$122.33 M(-28.7%)
$122.33 M(-48.8%)
Sep 2001
-
$238.88 M(+37.2%)
Jun 2001
-
$174.16 M(+44.3%)
Mar 2001
-
$120.73 M(-29.6%)
Dec 2000
$171.48 M(+528.5%)
$171.48 M(+6.0%)
Sep 2000
-
$161.79 M(+62.7%)
Jun 2000
-
$99.43 M(+249.0%)
Mar 2000
-
$28.49 M(+4.4%)
Dec 1999
$27.28 M(-86.6%)
$27.28 M(-25.9%)
Sep 1999
-
$36.80 M(-75.2%)
Jun 1999
-
$148.50 M(-3.7%)
Mar 1999
-
$154.20 M(-24.0%)
Dec 1998
$202.90 M(+25.5%)
$202.90 M(+12.1%)
Sep 1998
-
$181.00 M(+18.5%)
Jun 1998
-
$152.70 M(-11.5%)
Mar 1998
-
$172.60 M(+6.7%)
Dec 1997
$161.70 M(+285.4%)
$161.70 M(+29.9%)
Sep 1997
-
$124.50 M(+64.2%)
Jun 1997
-
$75.80 M(+11.6%)
Mar 1997
-
$67.90 M
Dec 1996
$41.96 M
-

FAQ

  • What is Quest Diagnostics Incorporated annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated annual cash & cash equivalents year-on-year change?
  • What is Quest Diagnostics Incorporated quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Quest Diagnostics Incorporated?
  • What is Quest Diagnostics Incorporated quarterly cash and cash equivalents year-on-year change?

What is Quest Diagnostics Incorporated annual cash & cash equivalents?

The current annual cash & cash equivalents of DGX is $549.00 M

What is the all time high annual cash & cash equivalents for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high annual cash & cash equivalents is $1.19 B

What is Quest Diagnostics Incorporated annual cash & cash equivalents year-on-year change?

Over the past year, DGX annual cash & cash equivalents has changed by -$137.00 M (-19.97%)

What is Quest Diagnostics Incorporated quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of DGX is $549.00 M

What is the all time high quarterly cash and cash equivalents for Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated all-time high quarterly cash and cash equivalents is $1.60 B

What is Quest Diagnostics Incorporated quarterly cash and cash equivalents year-on-year change?

Over the past year, DGX quarterly cash and cash equivalents has changed by $0.00 (0.00%)